药品合同销售组织市场报告| 2031 年增长预测

Publication Month : Oct 2023

  • Report Code : TIPRE00030074
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 221
Inquire Before Buy

PRICING

$4550

$3640

[研究报告]药品合同销售机构市场规模预计将从2022年的821202万美元增长到2030年的1582086万美元;预计 2022 年至 2030 年复合年增长率将达到 8.6%。

市场洞察和分析师观点:

药品合同销售组织与药品客户合作。正在开发的生物制剂数量的增加推动了对高科技开发和制造解决方案的需求。因此,企业正在加大研发投资,以创建合同智能平台,以加快严格监管的促销计划中的药物试验。新药上市数量的增加、药品研发活动的增加以及降低内部销售相关成本的需求不断增长,支持了市场的增长。数字技术的日益融合以及制药公司对增加产品销售的兴趣日益增长是加速市场增长的关键因素。此外,远程医疗和远程详细信息的使用不断增加也推动了市场的增长。此外,合同销售组织 (CSO) 在新兴市场的扩张正在加剧药品合同销售组织市场的竞争。

增长动力:< /u>

近年来,制药公司越来越多地采用创新策略来增加其产品的销量。这一领域的一个显着趋势是对药品合同销售组织 (CSO) 的高度依赖,将其作为其商业化努力的关键组成部分。这凸显了制药实体为应对市场复杂性而采取的积极主动的方法。通过与公民社会组织合作,这些公司可以利用专业的销售队伍,利用外部熟练程度来提高市场渗透率并优化销售业绩。这种协作模式使制药公司能够简化运营并专注于研发等核心能力,同时利用公民社会组织的定制专业知识来增强其产品的市场地位。制药公司和公民社会组织之间日益增强的协同反映了对资源优化的细致入微的理解,体现了对适应性的承诺以及对激烈竞争的制药领域不断变化的动态的敏锐认识。这种共生关系促进了收入最大化,并使制药企业在敏捷性和有针对性的市场战略对于持续成功至关重要的环境中进行战略定位。因此,制药公司对增加产品销售的兴趣日益增长,有助于药品合同销售组织的发展。

战略见解

报告细分和范围:

< span>药品合同销售组织市场根据服务、模块、治疗领域、最终用户和地理位置进行细分。根据服务,市场分为商业服务和非商业服务。从模块来看,药品合同销售组织市场分为联合模块和专用模块。根据治疗领域,市场分为心血管疾病、肿瘤、代谢性疾病、神经病学、骨科疾病、传染病等。就最终用户而言,药品合同销售组织市场分为生物制药公司和制药公司。药品合同销售组织市场根据地理位置分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、西班牙和欧洲其他地区)、亚太地区(澳大利亚) 、中国、日本、印度、韩国和亚太地区其他地区)、中东和非洲非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美和非洲中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)。

细分分析:

药品合同销售组织市场(按服务) ,分为商业服务和非商业服务。商业服务领域在 2022 年占据了更大的市场份额,预计 2022 年至 2030 年市场复合年增长率将更高。商业服务是指公民社会组织向制药公司提供的一系列服务,以支持其销售和营销工作。 CSO 是专门代表制药公司提供销售和营销服务的第三方组织。这些组织提供的商业服务包括销售人员外包、市场研究和分析、医疗代表培训、营销和促销支持、远程详细服务以及合规和监管支持。这些服务对于制药公司优化销售和营销策略、增强产品知识和销售技能、与关键意见领袖互动、遵守行业法规和推动业务增长至关重要。通过将这些职能外包给公民社会组织,制药公司可以利用他们的专业知识、资源和灵活性,使他们能够专注于自己的核心竞争力。

CMIC Holdings Co., LTD此类 CSO 提供全面的促销活动,包括针对特定产品或地区的活动。该公司的团队创建量身定制的提案并执行理想的解决方案来满足客户的要求,例如维持或扩大现有的产品份额。该公司的销售代表通过面对面和远程渠道向医疗保健专业人员提供药品信息和销售信息。

商业销售和营销在药品的整体收入中发挥着至关重要的作用公司。制药公司越来越多地投资于研究和技术开发活动,导致商业销售和营销对制药公司的整体收入至关重要。此外,制药公司对逐年增加收入越来越感兴趣,因此他们专注于推出新产品,这反过来又刺激了制药公司对这些商业服务的需求,以增加其销售额。

药品合同销售组织市场(按服务) 2022年和2030年

基于模块,药品合同销售组织市场分为联合模块和专用模块。联合组件细分市场在 2022 年占据了更大的市场份额,预计 2022 年至 2030 年将以更快的速度增长。 CSO 通过专用和联合模块提供服务。联合模块是指多个制药公司联合起来共享资源和专业知识以实现共同的销售和营销目标的协作方法。这些模块允许公司组建一个统一的团队来推广和销售所有参与公司的产品。通过合作,与单独运营相比,集团模块可以扩大市场范围、提高效率并降低成本。民间社会组织管理联合团队,但他们推广来自不同制药公司的产品。联合模块有助于推广非竞争性治疗领域的产品。辛迪加模块具有诸如提高市场渗透率、规模经济以及知识共享和创新机会等优势。辛迪加模块已经存在很长时间了,因为公司最初为营销和促销投入了一次性资金。总体而言,该模块为制药公司提供了一种协作方法,以加强其销售和营销工作并推动业务增长。

辛迪加团队还用于产品发布或抵制新产品竞争对手,特别适合季节性产品。联合团队包括销售经理和医疗代表团队,与不同制造商的产品合作,而不是相互竞争。合同通常以四个月的续签周期签订,72 名代表组成一个标准团队。在法国,MBO 和 CLI Innovation 等公司专注于合同销售人员,开展医疗代表和区域经理的招聘活动。如今,一些公司正在寻求短期合同销售外包,并更喜欢在产品发布中采用联合模块,尤其是抗感染药物等季节性产品。

基于治疗领域,药品合同销售组织市场细分为心血管疾病、肿瘤、代谢性疾病、神经病学、骨科疾病、传染病等。肿瘤学领域在 2022 年占据最大的市场份额,预计 2022 年至 2030 年复合年增长率最高。根据 GLOBOCAN 2020 估计,2020 年全球报告了约 1930 万新癌症病例(1810 万,不包括非黑色素瘤皮肤癌)和 1000 万癌症死亡,或近六分之一的死亡(990 万,不包括非黑色素瘤皮肤癌)。对用于肿瘤治疗和其他癌症治疗和治疗的药物的需求增加。肿瘤学是全球发展最快的治疗领域之一,预计未来将成为药品销售的主要组成部分,肿瘤治疗领域对药品合同销售外包的需求将不断增长。

制药公司期待在竞争激烈的市场中大规模推广其肿瘤产品,以获得整体市场的主要份额。此外,创新癌症疗法的推出也促进了肿瘤领域药品合同销售组织市场的增长。这些复杂的疗法需要专门的知识和专业知识,合同销售组织可以提供这些知识和专业知识,以便有效地营销和销售肿瘤药物。

此外,人们越来越关注个性化医疗和精准肿瘤学为制药 CSO 开辟了新的机遇。这些方法需要更深入地了解患者群体及其个人治疗需求,这可以通过市场研究和关键意见领袖 (KOL) 参与等制药 CSO 服务来实现。因此,由于癌症发病率不断上升,以及靶向治疗和免疫疗法等新颖和创新的癌症治疗和疗法的不断发展,预计未来几年肿瘤治疗领域对制药 CSO 的需求将继续扩大。< /span>

根据最终用户,药品合同销售组织市场分为生物制药公司和制药公司。制药公司细分市场将在 2022 年占据更大的市场份额。然而,生物制药公司细分市场预计将在 2022 年至 2030 年期间以最快的速度增长。制药公司是合同销售组织 (CSO) 的主要最终用户。这些公司利用 CSO 作为战略合作伙伴来加强其销售和营销工作、简化市场准入并优化资源配置。

由于以下原因,制药公司越来越多地转向 CSO 服务:全球范围内新的小分子药物上市数量不断增加,大量制药公司提供类似产品,以及公司在合同销售中大量采用新技术。此外,为制药公司招聘和留住高效的销售专业人员也具有挑战性;这支持了制药公司对 CSO 服务的需求。制药公司越来越多地寻求公民社会组织帮助他们快速建立强大的销售团队,降低销售团队的管理成本,节省招聘过程中的时间和精力,并发展兼职合同销售团队以消除投资需求。因此,制药公司越来越注重节省金钱和时间,这增加了药品合同销售组织市场的销售机会。

区域分析:

区域分析:

根据地理位置,药品合同销售组织市场分为五个关键区域:北美、欧洲、亚太地区、南美和北美地区。中美洲、中东和非洲非洲。 2022年,北美在全球市场中占据重要份额。该地区的市场增长归因于合同销售组织采用新技术、制药公司重视促进小分子和生物制药药物的销售,以及更加注重降低内部销售业务产生的成本。随着时间的推移,新药的上市数量激增。根据 IQVIA 的研发趋势报告,2021 年全球推出了 84 种新活性化合物,是前五年推出的两倍。随着国际药物发布的增加,预计对合同销售服务的需求将会增加。北美占据药品合同销售组织市场的最大份额。 EPS Corp. 等主要参与者; IQVIA 公司;和 Axxelus 推动了该地区的市场增长。

行业发展和未来机遇:

全球药品合同销售组织市场主要参与者采取的各种举措如下:

  1. 2022 年 9 月,IQVIA , Inc. 与制药公司 Dr. Reddy's Laboratories 合作。根据安排,IQVIA 向 Reddy 博士提供其精心策划的客户参与 (OCE) 平台的访问权限,以协助其 CRM 运营。根据合作伙伴关系,博士。Reddy's 向印度的所有营销用户和现场工作人员提供 IQVIA 的 OCE 应用程序,以便他们能够通过集成营销、客户管理、医学科学联络、销售和其他活动来更有效地吸引客户。
  2. 2021 年 7 月,ICON plc——一家为制药、生物技术、医疗器械以及政府和公共卫生公司提供外包药物和设备开发及商业化服务的全球供应商——收购了 PRA Health Sciences, Inc。此次合并增强了咨询、临床、 ICON 的商业服务组合、地理位置、治疗能力和数据驱动的医疗保健技术,旨在提供国际规模的专业知识和解决方案。

竞争格局和主要公司:

CMIC Holdings Co Ltd、Axxelus Inc、EPS Holdings Inc、MaBico SA、IQVIA Holdings Inc、Peak Pharma Solutions Inc、QFR Solutions LLC、Promoveo Health LLC、Syneos Health Inc 和 Mednext Pharmaceuticals Pvt Ltd 都是顶尖的药品合同销售组织。这些公司专注于新技术服务、现有服务的进步以及地域扩张,以满足不断增长的消费者需求全球需求。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment is dominating the pharmaceutical contract sales organizations market?

The pharmaceutical contract sales organizations market: by service, is segmented into commercial services and non-commercial services. In 2022, the commercial services segment held the largest share of the market and is expected to grow at the fastest rate during the coming years. Commercial services refer to the range of services provided by contract sales organizations (CSOs) to pharmaceutical companies to support their sales and marketing efforts. CSOs are third-party organizations specializing in delivering sales and marketing services on behalf of pharmaceutical companies.

What was the estimated pharmaceutical contract sales organizations market size in 2022?

The pharmaceutical contract sales organizations market was valued at US$ 8,212.02 million in 2022.

What are the growth estimates for the pharmaceutical contract sales organizations market till 2030?

The pharmaceutical contract sales organizations market is expected to be valued at US$ 15,820.86 million in 2030.

Who are the major players in the pharmaceutical contract sales organizations market?

The pharmaceutical contract sales organizations market majorly consists of the players, including CMIC Holdings Co. Ltd.; Axxelus; EPS Holdings, Inc.; MaBico, IQVIA, Inc.; Peak PharmA; QFR Solutions; Promoveo Health; Syneous Health Inc.; and Mednext Pharmaceuticals Pvt. Ltd;.

What are the driving factors for the pharmaceutical contract sales organizations market?

Key factors driving the market growth are the increasing integration of digital technologies and the growing interest of pharmaceutical companies to increase sales of products. However, quality issues associated with outsourcing hinder the pharmaceutical contract sales organizations market growth.

What are pharmaceutical contract sales organizations?

Pharmaceutical companies may outsource their sales and marketing functions to third parties, commonly referred to as contract sales organizations, under the pharmaceutical contract sales outsourcing (CSO) business model. Because of the financial benefits, the improved flexibility, and the easy access to specialized knowledge, this practice has gained popularity in the pharmaceutical sector. Companies that manage contract sales teams also offer training, hiring, and performance evaluation. Contract sales outsourcing does, however, come with some drawbacks, including the potential loss of sales process control and the requirement to uphold solid vendor relationships.

The List of Companies - Pharmaceutical Contract Sales Organizations Market

  1. CMIC Holdings Co., Ltd.
  2. Axxelus
  3. EPS Holdings, Inc. 
  4. MaBico
  5. IQVIA, Inc.
  6. Peak Pharma
  7. QFR Solutions
  8. Promoveo Health
  9. Syneous Health Inc.
  10. Mednext Pharmaceuticals Pvt. Ltd

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports